Site Search

This afternoon, the Pennsylvania State House passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Biomarker testing has revolutionized cancer treatment over the last few decades and is increasingly important in the treatment of other conditions, ...

... House Bill 73 as the 2023 legislative session ended. With the signature of Governor Michelle Lujan Grisham, the bill will expand access to biomarker testing statewide, helping to revolutionize cancer care in New Mexico.  In 2023, more than 11,000 New Mexicans are projected to be diagnosed with ... Governor doesn’t sign this bill into law, existing disparities in cancer outcomes by race, ethnicity, income, and geography could increase. Biomarker testing has become a game-changing part of cancer care in recent years as it’s a necessary first step in opening the door to targeted ...

This week, New Jersey lawmakers approved legislation to improve access to biomarker testing with a unanimous vote by the Assembly Appropriations Committee. Assembly Bill 4163 now awaits a vote on the Assembly floor. The Senate ... Committee last week, which now awaits further consideration by the Senate Budget & Appropriations Committee. Advocates with the New Jersey Biomarker Testing Coalition are hopeful that the bills will receive the necessary support to secure swift passage in the new year. Biomarker ...

Today, the Assembly Financial Institutions & Insurance Committee voted to improve New Jerseyans’ access to biomarker testing, advancing Assembly Bill 4163 out of committee. Championed by Assemblymembers Shavonda Sumter, Gary Schaer and Shama Haider, the proposal would ensure biomarker testing is covered by New Jersey-regulated insurance plans, including Medicaid, when medical and scientific evidence shows it would ...